Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03858231 · ClinicalTrials.gov registry record · Phase 4

Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

A Phase 4 study of Pain, Postoperative and Opioid Use, sponsored by Sanford Health.

Recruiting
Registry status
Phase 4
Development phase
148
Enrollment target
1
Study location

NCT03858231: Recruiting Phase 4 study of Pain, Postoperative and Opioid Use, sponsored by Sanford Health.

NCT03858231 is a Phase 4 study of Pain, Postoperative and Opioid Use that is actively recruiting participants, run by Sanford Health. The registered enrollment target is 148 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03858231, a Phase 4 study of Pain, Postoperative and Opioid Use, is actively recruiting participants, sponsored by Sanford Health.

RECRUITING
Registry status
Phase 4
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at pain management with opioids versus non-opioids after knee arthroscopy. This study will determine 1) whether the most commonly used non-narcotic medications provide pain relief comparable with the most commonly prescribed narcotic medications in patients undergoing arthroscopic knee surgery, and 2) whether patients' characteristics (gender, pre-operative knee symptoms, workers compensation status and employment status) affect pain level following surgery or medication usage.

Primary Outcome

Visual Analog Scale from 0 to 10 with 0 being no pain and 10 being worst possible, unbearable, excruciating pain

Interventions

  • DRUG Ibuprofen 600 mg
  • DRUG Norco 5Mg-325Mg Tablet
  • DRUG Acetaminophen 325Mg Tab

Study Locations (1)

North Dakota

  • Sanford Health - Fargo

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2018-10-29
Est. Completion 2028-01
Phase Phase 4
Sanford Health

34 total trials

What NCT03858231 shows while recruiting

NCT03858231 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower).

The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Ibuprofen 600 mg is the first listed.

NCT03858231 reports a single indexed study location in North Dakota.

Frequently Asked Questions

What is clinical trial NCT03858231 about?

NCT03858231 is a clinical study titled "Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery". The purpose of this study is to look at pain management with opioids versus non-opioids after knee arthroscopy. This study will determine 1) whether the most commonly used non-narcotic medications provide pain relief comparable with the most commonly prescribed narcotic medications in patients under...

What is the current status of trial NCT03858231?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 148 participants. The study started on 2018-10-29. Estimated completion is 2028-01.

What conditions does trial NCT03858231 study?

This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Knee Injuries.

What interventions are being tested in trial NCT03858231?

The interventions under investigation include: Ibuprofen 600 mg (DRUG), Norco 5Mg-325Mg Tablet (DRUG), Acetaminophen 325Mg Tab (DRUG).

Who is sponsoring clinical trial NCT03858231?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03858231 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03858231's enrollment target sits among peer trials

148 27th of 113 higher than 87 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

  • NCT04639297 · 148 participants · NA

    NeuroVision vs Standard Neuromonitoring

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03858231, the US trial registry maintained by the National Library of Medicine. NCT03858231 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.